Concepedia

Jutta Schreiber

JS

Statistics

Publications

4

Citations

143

H-Index

4

Active since

2020

Affiliations

National Center for Tumor Diseases(Current)

German Cancer Research Center

Noxxon Pharma (Germany)

Heidelberg University

Jutta Schreiber is an author at National Center for Tumor Diseases specializing in tumor immunology, cancer immunology, and oncology.

Publications per year

2020–2021

4

Publications

4

Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects

Meggy Suarez‐Carmona, Anja Williams, Jutta Schreiber et al. · Journal for ImmunoTherapy of Cancer · 2021 · 78 citations · Full text

Life Sciences, Immunology, Oncology +14

Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Jacek Hajda, Barbara Leuchs, Assia L. Angelova et al. · Clinical Cancer Research · 2021 · 42 citations · Full text

Medicine, Immunology, Oncology +17

A phase I dose-escalation and expansion study of intratumoral CV8102 as single-agent or in combination with anti-PD-1 antibodies in patients with advanced solid tumors.

Thomas Eigentler, Franz Bauernfeind, Jürgen C. Becker et al. · Journal of Clinical Oncology · 2020 · 13 citations

Life Sciences, Immunology, Oncology +17

1537P Phase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer

Niels Halama, Anja Williams, Meggy Suarez‐Carmona et al. · Annals of Oncology · 2020 · 10 citations

Medicine, Oncology, Pharmacology +16

1–4 of 4